-
Published 11/10/2023
Switzer A, Charidimou A, McCarter SJ, Vemuri P, Nguyen A, Przybelski SA, Lesnick TG, Rabinstein AA, Brown RD, Knopman DS, Petersen RC, Jack CR, Reichard RR, Graff-Radford J. Boston criteria v2.0 for cerebral amyloid angiopathy without hemorrhage: An MRI-neuropathological validation study. medRxiv. 2023 Nov 10. PMID: 37986913.
-
Published 9/14/2023
Rodriguez Lara F, Toro AR, Pinheiro A, Demissie S, Ekenze O, Martinez O, Parva P, Charidimou A, Ghosh S, DeCarli C, Seshadri S, Habes M, Maillard P, Romero JR. Relation of MRI-Visible Perivascular Spaces and Other MRI Markers of Cerebral Small Vessel Disease. Brain Sci. 2023 Sep 14; 13(9). PMID: 37759924.
-
Published 8/21/2023
Morotti A, Boulouis G, Nawabi J, Li Q, Charidimou A, Pasi M, Schlunk F, Shoamanesh A, Katsanos AH, Mazzacane F, Busto G, Arba F, Brancaleoni L, Giacomozzi S, Simonetti L, Warren AD, Laudisi M, Cavallini A, Gurol ME, Viswanathan A, Zini A, Casetta I, Fainardi E, Greenberg SM, Padovani A, Rosand J, Goldstein JN. Association Between Hematoma Expansion Severity and Outcome and Its Interaction With Baseline Intracerebral Hemorrhage Volume. Neurology. 2023 Oct 17; 101(16):e1606-e1613. PMID: 37604661.
-
Published 6/7/2023
Varkanitsa M, Peñaloza C, Charidimou A, Kiran S. Cerebral Small Vessel Disease Burden: An Independent Biomarker for Anomia Treatment Responsiveness in Chronic Stroke Patients With Aphasia. Arch Phys Med Rehabil. 2023 Oct; 104(10):1630-1637. PMID: 37290492.
-
Published 6/1/2023
Charidimou A, Greenberg SM. Boston criteria version 2.0 and non-haemorrhagic presentations - Authors' reply. Lancet Neurol. 2023 Jun; 22(6):466-467. PMID: 37210091.